• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COBAS E-ELECSYS ANTI-CCP; ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE (CCP)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COBAS E-ELECSYS ANTI-CCP; ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE (CCP) Back to Search Results
Catalog Number 05031656190
Device Problem High Test Results (2457)
Patient Problems No Consequences Or Impact To Patient (2199); No Known Impact Or Consequence To Patient (2692)
Event Date 09/01/2016
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi)#: (b)(4).
 
Event Description
The customer received questionable elecsys anti-ccp immunoassay results for one patient when compared to the results from elisa-assay of euroimmun assay and siemens immulite assay.The customer was using cobas e601 analyzer serial number (b)(4).The patient was to take part in a clinical study and was tested for anti-ccp and other study relevant markers.Due to the discrepancy in the anti-ccp results, the patient's participation in the study was in question.The customer wanted confirmation of the results in order to be sure of the "pre-characterization of this patient" for the study.The results from the e601 were 71.82 u/ml and 71.76 u/ml (72) (positive) which matched the patient's clinical picture.The result from the siemens assay was 2.2 u/ml (normal).The result from the elisa assay on 09/03/2016 was 7.8 u/ml (indeterminate).No adverse event was reported.The medical doctors in charge heavily criticized the elevated result and claimed an assay performance issue.Sample from the patient was submitted for investigation and was tested on a cobas e411 analyzer and an analytical e module analyzer.The results were found comparable to the customer's results and an interfering factor to streptavidin could be excluded.Based on the results, a product problem could not be found.
 
Manufacturer Narrative
Additional information was provided that the patient suffers from rheumatoid arthritis and received "methotrexat treatment" during the time the questionable results were generated.
 
Manufacturer Narrative
Additional information was received that the results were not used for any diagnostic purpose and were used only for testing of patient for participation in the clinical study.The results were not provided to a person making a treatment decision for the patient.The patient was not adversely affected in any way.
 
Manufacturer Narrative
A specific root cause could not be confirmed.From the information provided and the analysis of the sample, a general reagent issue could be excluded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COBAS E-ELECSYS ANTI-CCP
Type of Device
ANTIBODIES, ANTI-CYCLIC CITRULLINATED PEPTIDE (CCP)
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key5979361
MDR Text Key55697750
Report Number1823260-2016-01467
Device Sequence Number1
Product Code NHX
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K081338
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Health Professional
Type of Report Initial,Followup,Followup,Followup
Report Date 12/01/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number05031656190
Device Lot NumberASKU
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/05/2016
Initial Date FDA Received09/27/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
Supplement Dates FDA Received10/13/2016
10/17/2016
12/01/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age53 YR
-
-